Globus Medical Inc Revenue Growth Rates (GMED), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Globus Medical Inc   (NYSE: GMED)
 

GMED's Revenue Growth by Quarter and Year

Globus Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GMED Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 789.61
1st Quarter March 759.85
FY 1,549.46

GMEDs Annual Revenue
Globus Medical Inc 's Revenue in the fiscal year 2025 $ 2,938.93 millions
Globus Medical Inc 's Revenue in the fiscal year 2024 $ 2,519.36 millions
Globus Medical Inc 's Revenue in the fiscal year 2023 $ 1,568.48 millions
Globus Medical Inc 's Revenue in the fiscal year 2022 $ 1,022.84 millions
Globus Medical Inc 's Revenue in the fiscal year 2021 $ 958.10 millions




GMED Revenue second quarter 2026 Y/Y Growth Comment
Globus Medical Inc reported Revenue growth of 5.94% year on year in the second quarter 2026, to $ 789.61 millions, this is lower than Globus Medical Inc 's recent average Revenue increase of 19.07%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 111 other companies have achieved higher Revenue growth. While Globus Medical Inc ' s Revenue increase of 5.94% ranks overall at the positon no. 2158 in the second quarter 2026.


GMED Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 25.73 % 6.61 % 124.6 %
3rd Quarter September - 22.91 % 63.1 % 50.95 %
2nd Quarter June 5.94 % 18.37 % 115.93 % 10.61 %
1st Quarter March 27.04 % -1.41 % 119.26 % 20.01 %
FY   - 16.65 % 60.62 % -

Financial Statements
Globus Medical Inc 's second quarter 2026 Revenue $ 789.61 millions GMED's Income Statement
Globus Medical Inc 's second quarter 2025 Revenue $ 745.34 millions Quarterly GMED's Income Statement


GMED Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 7.46 % 5.05 % 60.71 %
3rd Quarter September - 3.18 % -0.63 % 31.55 %
2nd Quarter June 3.92 % 24.61 % 3.79 % 5.4 %
1st Quarter March -8.06 % -9 % -1.6 % 0.8 %
FY (Year on Year)   - 16.65 % 60.62 % -


Back to GMED Growth rate Comparisons >> Back to GMED Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #318
Overall #2158

Revenue Y/Y Growth Statistics
High Average Low
124.6 % 19.07 % -23.45 %
(Jun 30 2024)  
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #318
Overall #2158
Revenue Y/Y Growth Statistics
High Average Low
124.6 % 19.07 % -23.45 %
(Jun 30 2024)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Globus Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
60.71 % 4.47 % -21.86 %
(Dec 31 2023)  


GMED's II. Quarter Q/Q Revenue Comment
Globus Medical Inc achieved in the II. Quarter 2026 below company average Revenue growth of 3.92% quarter on quarter, to $ 789.61 millions.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Globus Medical Inc 's Revenue growth quarter on quarter, overall rank is 1252.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1252
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1252
Revenue Q/Q Growth Statistics
High Average Low
60.71 % 4.47 % -21.86 %
(Dec 31 2023)  


GMED's II. Quarter Q/Q Revenue Comment
Globus Medical Inc achieved in the II. Quarter 2026 below company average Revenue growth of 3.92% quarter on quarter, to $ 789.61 millions.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Globus Medical Inc 's Revenue growth quarter on quarter, overall rank is 1252.


Globus Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 3,144.93 $ 3,100.66 $ 2,938.93 $ 2,769.80 $ 2,626.46
Y / Y Revenue Growth (TTM) 19.74 % 23.49 % 16.65 % 11.75 % 17.43 %
Year on Year Revenue Growth Overall Ranking # 732 # 1163 # 1223 # 820 # 448
Seqeuential Revenue Change (TTM) 1.43 % 5.5 % 6.11 % 5.46 % 4.61 %
Seq. Revenue Growth (TTM) Overall Ranking # 2123 # 2492 # 1500 # 473 # 623


Cumulative Revenue growth Comment
Assuming the Globus Medical Inc 's fiscal year would have ended in Jun 30 2026, Globus Medical Inc would have reprted above average annual Revenue increase of 19.74% year on year, of $ 3,145 millions.
This marks a slow-down of the companys growth trends and from the 23.49% improvement in Mar 31 2026.

In the Healthcare sector 188 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 732, from total ranking in previous quarter at 1163.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 63
Healthcare Sector # 189
Overall # 985

Revenue TTM Y/Y Growth Statistics
High Average Low
103.89 %
 18.25 %
-0.31 %
(Jun 30 2024)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 315
S&P 500 # 2123
Cumulative Revenue growth Comment
Assuming the Globus Medical Inc 's fiscal year would have ended in Jun 30 2026, Globus Medical Inc would have reprted above average annual Revenue increase of 19.74% year on year, of $ 3,145 millions.
This marks a slow-down of the companys growth trends and from the 23.49% improvement in Mar 31 2026.

In the Healthcare sector 188 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 732, from total ranking in previous quarter at 1163.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 63
Healthcare Sector # 189
Overall # 985

Revenue TTM Y/Y Growth Statistics
High Average Low
103.89 %
18.25 %
-0.31 %
(Jun 30 2024)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 315
S&P 500 # 2123




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GMED's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Interpace Biosciences Inc 10.33%$ 10.331 millions
Warby Parker Inc 10.25%$ 10.253 millions
Neuronetics Inc 10.25%$ 10.249 millions
Elanco Animal Health Incorporated10.23%$ 10.234 millions
Quest Diagnostics Inc10.21%$ 10.214 millions
Gilead Sciences Inc 10.18%$ 10.181 millions
Lifeloc Technologies Inc 10.16%$ 10.163 millions
Abbvie Inc 10.16%$ 10.160 millions
Concentra Group Holdings Parent Inc 10.03%$ 10.030 millions
Lemaitre Vascular Inc 10.02%$ 10.017 millions
Amneal Pharmaceuticals Inc 9.93%$ 9.934 millions
Merit Medical Systems Inc9.79%$ 9.792 millions
Idexx Laboratories Inc9.73%$ 9.728 millions
Lenz Therapeutics Inc 9.72%$ 9.720 millions
Encompass Health Corporation9.58%$ 9.584 millions
Trisalus Life Sciences Inc 9.57%$ 9.567 millions
Amgen Inc 9.53%$ 9.533 millions
Sotera Health Company9.45%$ 9.452 millions
Illumina Inc 9.44%$ 9.443 millions
Stryker Corp9.42%$ 9.415 millions
International Stem Cell Corporation9.32%$ 9.318 millions
Cytosorbents Corporation9.29%$ 9.292 millions
Resmed Inc 9.22%$ 9.222 millions
Fate Therapeutics Inc 9.18%$ 9.177 millions
Bausch and Lomb Corp9.08%$ 9.077 millions
Pacs Group Inc 9.07%$ 9.071 millions
Electromed Inc 8.97%$ 8.968 millions
National Healthcare Corp8.83%$ 8.833 millions
Chemed Corporation8.80%$ 8.800 millions
Tactile Systems Technology Inc 8.76%$ 8.763 millions


About Globus Medical Inc Revenue Growth Rates (GMED), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Globus Medical Inc (CIK 1237831).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-054450
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Globus Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.